SPECT and neuropsychological measures of lithium toxicity [1]

Australian and New Zealand Journal of Psychiatry

Volumn 40, Issue 3, 2006, Pages 277-

  Sheehan, William ^a   Valtinson, Gale ^b   Thurber, Steven ^c  

^a Rice Memorial Hospital   (United States)

^b Associated Clinic of Psychology   (United States)

^c Woodland Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; LITHIUM SALT; LORAZEPAM; METRONIDAZOLE; QUETIAPINE;

AGED; ATTENTION DISTURBANCE; BIPOLAR DISORDER; BRAIN DYSFUNCTION; CASE REPORT; COGNITIVE DEFECT; CONFUSION; DRUG POTENTIATION; HUMAN; LETTER; MAINTENANCE THERAPY; MALE; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; SHORT TERM MEMORY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPEECH DISORDER; URINARY TRACT INFECTION;

AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; CEREBELLUM; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM CARBONATE; LORAZEPAM; MALE; NEUROPSYCHOLOGICAL TESTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33644914722     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2006.01786_1.x     Document Type: Letter

References (1)

1. Kores B, Lader MH. Irreversible lithium neurotoxicity: An overview. Clinical Neuropharmacology 1997; 20:283-299.